Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
PURPOSE/OBJECTIVES: To comprehensively assess the patient and illness or treatment factors that may predict nonadherence to adjuvant endocrine therapy and to explore whether an interaction occurs between these factors in women with breast cancer. DESIGN: Repeated-measures design. SETTING: The Outpatient Services of the Women's Cancer Program at the University of Pittsburgh Cancer Institute and participants' homes. SAMPLE: 91 women with early-stage breast cancer who received endocrine therapy. METHODS: Adherence was assessed continuously for the first 18 months of endocrine therapy. Patient and illness or treatment factors were assessed at four time points (Time 1 to Time 4). Time 1 (baseline) was within two weeks prior to the initiation of endocrine therapy. Times 2-4 occurred at six-month intervals, as many as 18 months after Time 1. MAIN RESEARCH VARIABLES: Adherence, patient factors, and illness or treatment factors. FINDINGS: Adherence to endocrine therapy declined significantly during the first 18 months of treatment in women with breast cancer. The presence of negative mood and symptoms before starting treatment predicted nonadherence to endocrine therapy over time. Perceptions of financial hardship, symptoms, disease stage, and more complex medication regimens intensified the effect of negative mood on adherence over time. CONCLUSIONS: Women with breast cancer may be at risk for nonadherence to prescribed endocrine therapy if they experience depression or anxiety and symptoms prior to initiating therapy. IMPLICATIONS FOR NURSING: Oncology nurses should be alert to women with breast cancer who are depressed or anxious or who are experiencing symptoms. Management of negative mood and symptoms may result in better adherence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated anxiety predicts nonadherence to recommended therapies, [23][24][25] higher use and costs of medical care, [26][27][28] and possibly cancer recurrence.29”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [24]
Citations
Cites
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Horne, R., Weinman, J., & Hankins, M. (1999) · Psychology & Health · doi:10.1080/08870449908407311 · Cited by 2,372 · cited 1×
“Perceived treatment efficacy was evaluated with the 10-item Beliefs About Medicines Questionnaire (BMQ)–specific subscale (Horne, Weinman, & Hankins, 1999).”
Measuring the Functional Components of Social Support
Cohen, S., Mermelstein, R., Kamarck, T., & Hoberman, H. M. (1985) · Social Support: Theory, Research and Applications · doi:10.1007/978-94-009-5115-0_5 · Cited by 2,296 · cited 2×
“Test-retest correlations were 0.87 for two days, 0.7 for six weeks, and 0.74 for six months (Cohen et al., 1985).”
InfluentialSelf-citationPatient adherence to treatment: three decades of research. A comprehensive review
Vermeire, E., Hearnshaw, H., Van Royen, P., & Denekens, J. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00363.x · Cited by 1,833 · cited 1×
“Although the potential negative impact of financial hardship related to disease management on nonadherence has been explored (Griffith, 1990; Morris & Schulz, 1992; Vermeire, Hearnshaw, Van Royen, & Denekens, 2001), little is known about the role of financial hardship on”
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067 · cited 1×
“Although the potential negative impact of financial hardship related to disease management on nonadherence has been explored (Griffith, 1990; Morris & Schulz, 1992; Vermeire, Hearnshaw, Van Royen, & Denekens, 2001), little is known about the role of financial hardship on”
Neuropsychological assessment.
Garb, H. N. (2004) · Studying the clinician: Judgment research and psychological assessment. · doi:10.1037/10299-006 · Cited by 876
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Leukemia, E. I. C. M. (2013) · Blood · doi:10.1182/blood-2013-03-490003 · Cited by 592
Konecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588 · cited 1×
“About 80% of breast cancers express hormone receptors (Konecny et al., 2003).”
Research works printed but not linked: 3
- D. McNair, 1992, EdITS manual for the profile of mood states
- H. Nelson, 1981, National adult reading test (NART) manual
- O. Spreen, 1998, A compendium of neuropsychogical test: Administration, norms, and commentary
Cited by
Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes
Smith, G. L., Lopez-Olivo, M. A., Advani, P. G., Ning, M. S., Geng, Y., Giordano, S. H., & Volk, R. J. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.7305 · Cited by 437
A Systematic Review of Adherence to Oral Antineoplastic Therapies
Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., & Pirl, W. F. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0405 · Cited by 344
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors
Bargon, C. A., Batenburg, M. C. T., van Stam, L. E., Mink van der Molen, D. R., van Dam, I. E., van der Leij, F., Baas, I. O., Ernst, M. F., Maarse, W., Vermulst, N., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa104 · Cited by 268
Mausbach, B. T., Schwab, R. B., & Irwin, S. A. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3471-7 · Cited by 164
Metadata
- Authors
- Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., Donovan, H. S., Dunbar-Jacob, J., Jankowitz, R. C., Rosenzweig, M. Q., Sherwood, P. R., & Sereika, S. M.
- Affiliations
- UPMC Hillman Cancer Center (US)
- University of Pittsburgh (US)
- ORCID
- Venue
- Oncology Nursing Forum
- Publisher
- Oncology Nursing Society (ONS)
- Published
- 2014-04-25
- Volume
- 41
- Issue
- 3
- Pages
- 274-285
- ISSN
- 0190-535X (ISSN-L)
- 1538-0688
- PMC
- PMC4090095
- OpenAlex
- W1992203573
- Cited by
- 131
- References
- 50
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 15 · 2020: 17 · 2019: 11 · 2018: 12 · 2017: 15 · 2016: 8 · 2015: 8 · 2014: 1
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncology nursing forum (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000005)
- National Cancer Institute (R01CA107408)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, adjuvant endocrine therapy, medication adherence, non-compliance, negative mood, depression, anxiety, financial hardship, symptom burden, disease stage, medication regimen complexity, predictors of non-adherence
- MeSH terms
- Adolescent, Adult, Affect, Aged, Breast Neoplasms, Depression, Female, Follow-Up Studies, Forecasting, Humans, Middle Aged, Patient Compliance, Pennsylvania, Socioeconomic Factors, Tamoxifen, Time Factors, Comorbidity, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer. https://app.cochat.ai/papers/10.1188/14.onf.274-285
- The paper
- Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., Donovan, H. S., Dunbar-Jacob, J., Jankowitz, R. C., Rosenzweig, M. Q., Sherwood, P. R., & Sereika, S. M. (2014). Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer. Oncology Nursing Forum. https://doi.org/10.1188/14.onf.274-285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.